Proteasome inhibition modeling nigral neuron degeneration in Parkinson's disease
- PMID: 20649845
- DOI: 10.1111/j.1471-4159.2010.06914.x
Proteasome inhibition modeling nigral neuron degeneration in Parkinson's disease
Abstract
Impairment of the ubiquitin proteasome system (UPS) has been proposed to play an important role in the pathogenesis of Parkinson's disease (PD). Mice with UPS impairment in the nigra have been used for investigating mechanisms underlying neurodegeneration and for testing pre-clinical drugs to treat PD. However, the pathological, biochemical and behavioral features of UPS impairment animal model of PD have not been fully evaluated. For this purpose, we developed a UPS impairment model of nigral dopamine (DA) neuron degeneration by microinjection with proteasome inhibitors lactacystin, PSI or MG-132 into the medial forebrain bundle (iMFB) of C57BL/6 mice and then systematically examined the animal's locomotor activities, and various pathological and biochemical markers of PD. We found that lactacystin iMFB induced a sustained DA neuron degeneration, which can be reproduced by PSI iMFB and MG-132 iMFB. In the animal model, DA neuron degenerated preferentially in the substantia nigra, accompanied by profound inhibition of proteasomal activity, activation of caspase 3, elevated insoluble ubiquitin conjugates and α-synuclein positive inclusion-like granules, activated glia, and decreased motor activities. Thus, this model recapitulates many neuropathological and behavioral features of PD, rendering it likely suitable for studying the mechanisms of nigral DA neuron degeneration and for testing the potential anti-PD medications.
© 2010 The Authors. Journal Compilation © 2010 International Society for Neurochemistry.
Similar articles
-
Multiple molecular pathways are involved in the neuroprotection of GDNF against proteasome inhibitor induced dopamine neuron degeneration in vivo.Exp Biol Med (Maywood). 2008 Jul;233(7):881-90. doi: 10.3181/0712-RM-329. Epub 2008 Apr 29. Exp Biol Med (Maywood). 2008. PMID: 18445767
-
Neuroprotection by iron chelator against proteasome inhibitor-induced nigral degeneration.Biochem Biophys Res Commun. 2005 Jul 29;333(2):544-9. doi: 10.1016/j.bbrc.2005.05.150. Biochem Biophys Res Commun. 2005. PMID: 15950935
-
Prevention and restoration of lactacystin-induced nigrostriatal dopamine neuron degeneration by novel brain-permeable iron chelators.FASEB J. 2007 Dec;21(14):3835-44. doi: 10.1096/fj.07-8386com. Epub 2007 Aug 9. FASEB J. 2007. PMID: 17690154
-
Role of iron in UPS impairment model of Parkinson's disease.Parkinsonism Relat Disord. 2014 Jan;20 Suppl 1:S158-61. doi: 10.1016/S1353-8020(13)70038-5. Parkinsonism Relat Disord. 2014. PMID: 24262171 Review.
-
Gene expression profiling of sporadic Parkinson's disease substantia nigra pars compacta reveals impairment of ubiquitin-proteasome subunits, SKP1A, aldehyde dehydrogenase, and chaperone HSC-70.Ann N Y Acad Sci. 2005 Aug;1053:356-75. doi: 10.1196/annals.1344.031. Ann N Y Acad Sci. 2005. PMID: 16179542 Review.
Cited by
-
Impaired proteasome activity and neurodegeneration with brain iron accumulation in FBXO7 defect.Ann Clin Transl Neurol. 2020 Aug;7(8):1436-1442. doi: 10.1002/acn3.51095. Epub 2020 Aug 6. Ann Clin Transl Neurol. 2020. PMID: 32767480 Free PMC article.
-
The Proteasome Inhibition Model of Parkinson's Disease.J Parkinsons Dis. 2017;7(1):31-63. doi: 10.3233/JPD-160921. J Parkinsons Dis. 2017. PMID: 27802243 Free PMC article. Review.
-
α-Synuclein fate is determined by USP9X-regulated monoubiquitination.Proc Natl Acad Sci U S A. 2011 Nov 15;108(46):18666-71. doi: 10.1073/pnas.1105725108. Epub 2011 Nov 7. Proc Natl Acad Sci U S A. 2011. PMID: 22065755 Free PMC article.
-
ZA-II-05, a novel NMDA-receptor antagonist reverses vanadium-induced neurotoxicity in Caenorhabditis elegans (C. elegans).BMC Neurosci. 2024 Oct 28;25(1):56. doi: 10.1186/s12868-024-00902-y. BMC Neurosci. 2024. PMID: 39468459 Free PMC article.
-
Protein degradation pathways in Parkinson's disease: curse or blessing.Acta Neuropathol. 2012 Aug;124(2):153-72. doi: 10.1007/s00401-012-1004-6. Epub 2012 Jun 29. Acta Neuropathol. 2012. PMID: 22744791 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials